Emerald Pathway is categorized under Dispensary, Operated By Physicians in Denver, CO and active since 2010.
Emerald Pathway was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Dispensary, Operated By Physicians business, which does work in the B2C market, and is classified as a Dispensary, Operated By Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact John Niforos at the company’s single location by writing to 4966 Leetsdale Drive, Denver, Colorado CO 80246 or by phoning (720) 389-7442. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Emerald Pathway |
| Contact Person: | John Niforos |
| Address: | 4966 Leetsdale Drive, Denver, Colorado 80246 |
| Phone Number: | (720) 389-7442 |
| Website Address: | emeraldpathwaydenver.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Dispensary, Operated By Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Emerald Pathway was started in 2010 to provide professional Dispensary, Operated By Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John Niforos for inquiries that concern Emerald Pathway by calling the company number (720) 389-7442, as your correspondence is most welcome. Additionally, the physical location of the single location of Emerald Pathway can be found at the coordinates 39.708553,-104.930035 as well as the street address 4966 Leetsdale Drive in Denver, Colorado 80246.
For its online presence, you may visit Emerald Pathway’s website at emeraldpathwaydenver.com and engage with its social media outlets through on Twitter and on Facebook.